中国免疫学杂志
中國免疫學雜誌
중국면역학잡지
Chinese Journal of Immunology
2015年
10期
1400-1403
,共4页
宫颈癌%上调基因-4%Wnt/β-catenin信号通路
宮頸癌%上調基因-4%Wnt/β-catenin信號通路
궁경암%상조기인-4%Wnt/β-catenin신호통로
Cervical cancer%Upregulated gene 4%Wnt/β-catenin signaling pathway
目的:分析上调基因-4(URG4)在宫颈癌中的表达,并观察分析抑制URG4对宫颈癌的治疗作用及机制。方法:Western blot 法分析URG4在宫颈癌组织及癌旁组织中的表达差异。选择16只雄性BALB/c 裸鼠,喂养至6周龄后随机分为对照组(Control 组)及观察组(Observation 组),每组各8只。Control 组小鼠于右侧背部皮下接种宫颈癌细胞(SiHa cells)。Observation 组小鼠背部皮下接种URG4-siRNA 转染的宫颈癌细胞(URG4-siRNA SiHa cells)。干预后4周处死小鼠,分析对比小鼠肿瘤生长情况及Wnt/β-catenin 信号通路的改变。结果:URG4在人宫颈癌组织中呈现高表达,显著高于癌旁组织(P<0.05)。干预结束后,观察组小鼠肿瘤组织内URG4表达量显著低于对照组(P<0.05);体重明显高于对照组(P<0.05);肿瘤组织重量显著低于对照组(P<0.05)。观察组小鼠肿瘤组织内Ki67表达量显著低于对照组(P<0.05)。观察组小鼠肿瘤组织内CyclinD1、β-catenin 及C-myc 的表达均显著低于对照组,相比较差异均具有统计学意义(P<0.05)。结论:URG4在人宫颈癌中呈现高表达,抑制URG4的表达可能通过抑制Wnt/β-catenin 信号通路而发挥抗肿瘤效应。
目的:分析上調基因-4(URG4)在宮頸癌中的錶達,併觀察分析抑製URG4對宮頸癌的治療作用及機製。方法:Western blot 法分析URG4在宮頸癌組織及癌徬組織中的錶達差異。選擇16隻雄性BALB/c 裸鼠,餵養至6週齡後隨機分為對照組(Control 組)及觀察組(Observation 組),每組各8隻。Control 組小鼠于右側揹部皮下接種宮頸癌細胞(SiHa cells)。Observation 組小鼠揹部皮下接種URG4-siRNA 轉染的宮頸癌細胞(URG4-siRNA SiHa cells)。榦預後4週處死小鼠,分析對比小鼠腫瘤生長情況及Wnt/β-catenin 信號通路的改變。結果:URG4在人宮頸癌組織中呈現高錶達,顯著高于癌徬組織(P<0.05)。榦預結束後,觀察組小鼠腫瘤組織內URG4錶達量顯著低于對照組(P<0.05);體重明顯高于對照組(P<0.05);腫瘤組織重量顯著低于對照組(P<0.05)。觀察組小鼠腫瘤組織內Ki67錶達量顯著低于對照組(P<0.05)。觀察組小鼠腫瘤組織內CyclinD1、β-catenin 及C-myc 的錶達均顯著低于對照組,相比較差異均具有統計學意義(P<0.05)。結論:URG4在人宮頸癌中呈現高錶達,抑製URG4的錶達可能通過抑製Wnt/β-catenin 信號通路而髮揮抗腫瘤效應。
목적:분석상조기인-4(URG4)재궁경암중적표체,병관찰분석억제URG4대궁경암적치료작용급궤제。방법:Western blot 법분석URG4재궁경암조직급암방조직중적표체차이。선택16지웅성BALB/c 라서,위양지6주령후수궤분위대조조(Control 조)급관찰조(Observation 조),매조각8지。Control 조소서우우측배부피하접충궁경암세포(SiHa cells)。Observation 조소서배부피하접충URG4-siRNA 전염적궁경암세포(URG4-siRNA SiHa cells)。간예후4주처사소서,분석대비소서종류생장정황급Wnt/β-catenin 신호통로적개변。결과:URG4재인궁경암조직중정현고표체,현저고우암방조직(P<0.05)。간예결속후,관찰조소서종류조직내URG4표체량현저저우대조조(P<0.05);체중명현고우대조조(P<0.05);종류조직중량현저저우대조조(P<0.05)。관찰조소서종류조직내Ki67표체량현저저우대조조(P<0.05)。관찰조소서종류조직내CyclinD1、β-catenin 급C-myc 적표체균현저저우대조조,상비교차이균구유통계학의의(P<0.05)。결론:URG4재인궁경암중정현고표체,억제URG4적표체가능통과억제Wnt/β-catenin 신호통로이발휘항종류효응。
Objective:To analyze the curative effect of suppression expression of URG4 on cervical cancer mice and the possible mechanisms.Methods:The expression of URG4 were analyzed in cervical cancer tissues and para-carcinoma tissues.16 male BALB/c nude mice were divided into Group A ( inoculated with URG4-siRNA SiHa cells) and Group B ( inoculated with SiHa cells) . After 4 weeks,mice were executed and analyzed.Results:The expression of URG4 were higher in human cervical cancer tissues than that in para-carcinoma tissues ( P<0.05).After experiment,Group A had a lower tumor weight,but a higher body weight than these of Group B,the difference was statistically significant (P<0.05).Group A mice had a lower levels of URG4 in tumor than that of Group B mice (P<0.05).Group A mice had a lower levels of Ki67 in tumor than that of Group B mice,the difference was statistically significant (P<0.05).Group A mice had lower levels of CyclinD1,β-catenin and C-myc in tumor than these of Group B mice (P<0.05). Conclusion:The expression of URG4 in cervical cancer tissue is up-regulation.Suppression expression of URG4 can suppress tumor growth in vivo,which may though suppress the Wnt/β-catenin signaling pathway.